These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Murine model for assessment of Plasmodium falciparum transmission-blocking vaccine using transgenic Plasmodium berghei parasites expressing the target antigen Pfs25. Mlambo G; Maciel J; Kumar N Infect Immun; 2008 May; 76(5):2018-24. PubMed ID: 18316385 [TBL] [Abstract][Full Text] [Related]
10. Immunogenicity of Plasmodium falciparum sexual stage antigens: implications for the design of a transmission blocking vaccine. Kaslow DC Immunol Lett; 1990 Aug; 25(1-3):83-6. PubMed ID: 1704352 [TBL] [Abstract][Full Text] [Related]
11. A novel plant-produced Pfs25 fusion subunit vaccine induces long-lasting transmission blocking antibody responses. Jones RM; Chichester JA; Manceva S; Gibbs SK; Musiychuk K; Shamloul M; Norikane J; Streatfield SJ; van de Vegte-Bolmer M; Roeffen W; Sauerwein RW; Yusibov V Hum Vaccin Immunother; 2015; 11(1):124-32. PubMed ID: 25483525 [TBL] [Abstract][Full Text] [Related]
12. Induction of Plasmodium falciparum transmission-blocking antibodies in nonhuman primates by a combination of DNA and protein immunizations. Coban C; Philipp MT; Purcell JE; Keister DB; Okulate M; Martin DS; Kumar N Infect Immun; 2004 Jan; 72(1):253-9. PubMed ID: 14688103 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of a Plasmodium-Specific Carrier Protein To Enhance Production of Recombinant Parzych EM; Miura K; Ramanathan A; Long CA; Burns JM Infect Immun; 2018 Jan; 86(1):. PubMed ID: 28993460 [TBL] [Abstract][Full Text] [Related]
14. The Plasmodium falciparum Cell-Traversal Protein for Ookinetes and Sporozoites as a Candidate for Preerythrocytic and Transmission-Blocking Vaccines. Espinosa DA; Vega-Rodriguez J; Flores-Garcia Y; Noe AR; Muñoz C; Coleman R; Bruck T; Haney K; Stevens A; Retallack D; Allen J; Vedvick TS; Fox CB; Reed SG; Howard RF; Salman AM; Janse CJ; Khan SM; Zavala F; Gutierrez GM Infect Immun; 2017 Feb; 85(2):. PubMed ID: 27895131 [TBL] [Abstract][Full Text] [Related]
15. A novel malaria protein, Pfs28, and Pfs25 are genetically linked and synergistic as falciparum malaria transmission-blocking vaccines. Duffy PE; Kaslow DC Infect Immun; 1997 Mar; 65(3):1109-13. PubMed ID: 9038325 [TBL] [Abstract][Full Text] [Related]
16. Structural and Immunological Characterization of Recombinant 6-Cysteine Domains of the Plasmodium falciparum Sexual Stage Protein Pfs230. MacDonald NJ; Nguyen V; Shimp R; Reiter K; Herrera R; Burkhardt M; Muratova O; Kumar K; Aebig J; Rausch K; Lambert L; Dawson N; Sattabongkot J; Ambroggio X; Duffy PE; Wu Y; Narum DL J Biol Chem; 2016 Sep; 291(38):19913-22. PubMed ID: 27432885 [TBL] [Abstract][Full Text] [Related]
17. Fusion to Tetrahymena thermophila granule lattice protein 1 confers solubility to sexual stage malaria antigens in Escherichia coli. Agrawal A; Bisharyan Y; Papoyan A; Bednenko J; Cardarelli J; Yao M; Clark T; Berkmen M; Ke N; Colussi P Protein Expr Purif; 2019 Jan; 153():7-17. PubMed ID: 30081196 [TBL] [Abstract][Full Text] [Related]
18. A region of Plasmodium falciparum antigen Pfs25 that is the target of highly potent transmission-blocking antibodies. Stowers AW; Keister DB; Muratova O; Kaslow DC Infect Immun; 2000 Oct; 68(10):5530-8. PubMed ID: 10992450 [TBL] [Abstract][Full Text] [Related]
20. Transmission-blocking activity induced by malaria vaccine candidates Pfs25/Pvs25 is a direct and predictable function of antibody titer. Miura K; Keister DB; Muratova OV; Sattabongkot J; Long CA; Saul A Malar J; 2007 Aug; 6():107. PubMed ID: 17686163 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]